Cord blood clues: scientists hunt for HHT treatment targets
NCT ID NCT05632484
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 32 times
Summary
This study looked at cells from the umbilical cords and cord blood of newborns who have a parent with hereditary hemorrhagic telangiectasia (HHT), a rare disorder that causes abnormal blood vessels and bleeding. Researchers grew these cells in the lab to compare their genes and behavior with cells from healthy babies. The goal was to find new targets for future HHT treatments. The study involved 16 newborns and did not offer any direct treatment or benefit to them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY HAEMORRHAGIC TELANGIECTASIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Estaing
Clermont-Ferrand, 63100, France
-
Hôpital Femme-mère-Enfant
Bron, 69677, France
-
Hôpital St Eloi
Montpellier, 34295, France
Conditions
Explore the condition pages connected to this study.